ASX - By Stock
|
IHL Biotech |
Re:
IHL - INCANNEX - HOLDERS RESEARCH
|
|
rhino78
|
1.2K |
536K |
25 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
1.2K
|
536K
|
25
|
|
ASX - By Stock
|
IHL |
Re:
Ann: APIRx Acquisition Presentation
|
|
rhino78
|
74 |
34K |
6 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
74
|
34K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Ann: APIRx Acquisition Presentation
|
|
rhino78
|
74 |
34K |
41 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
74
|
34K
|
41
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Loyalty Option Issue Raises $23.6M
|
|
rhino78
|
133 |
48K |
30 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
133
|
48K
|
30
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
rhino78
|
3.0K |
1.1M |
34 |
23/04/22 |
23/04/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
34
|
|
ASX - By Stock
|
BET |
Re:
Ann: Trading Halt
|
|
rhino78
|
87 |
46K |
3 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
87
|
46K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Loyalty Options Prospectus
|
|
rhino78
|
153 |
68K |
45 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
153
|
68K
|
45
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex to Acquire APIRx Pharmaceuticals
|
|
rhino78
|
460 |
148K |
17 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
460
|
148K
|
17
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex to Acquire APIRx Pharmaceuticals
|
|
rhino78
|
460 |
148K |
18 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
460
|
148K
|
18
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X positive phase 2 clinical trial results
|
|
rhino78
|
389 |
161K |
42 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
389
|
161K
|
42
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
rhino78
|
191 |
79K |
3 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
191
|
79K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
15 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
19K
|
6.6M
|
15
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
32 |
26/02/22 |
26/02/22 |
ASX - By Stock
|
19K
|
6.6M
|
32
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Update on Nasdaq Listing
|
|
rhino78
|
751 |
264K |
19 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
751
|
264K
|
19
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Update on Nasdaq Listing
|
|
rhino78
|
751 |
264K |
9 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
751
|
264K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
19 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
19K
|
6.6M
|
19
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
17 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
19K
|
6.6M
|
17
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
14 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
19K
|
6.6M
|
14
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
rhino78
|
59 |
19K |
12 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
59
|
19K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
24 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
19K
|
6.6M
|
24
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
21 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
19K
|
6.6M
|
21
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
14 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
19K
|
6.6M
|
14
|
|
ASX - By Stock
|
IHL |
Re:
Ann: CEO Address at FY21 A G M
|
|
rhino78
|
87 |
27K |
2 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
87
|
27K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Update on Nasdaq Listing
|
|
rhino78
|
751 |
264K |
30 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
751
|
264K
|
30
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X Phase 2 Trial Dosing Completed and pre-IND Update
|
|
rhino78
|
54 |
26K |
64 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
54
|
26K
|
64
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Update on Nasdaq Listing
|
|
rhino78
|
751 |
264K |
8 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
751
|
264K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Update on Nasdaq Listing
|
|
rhino78
|
751 |
264K |
13 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
751
|
264K
|
13
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Update on Nasdaq Listing
|
|
rhino78
|
751 |
264K |
47 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
751
|
264K
|
47
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
10 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
19K
|
6.6M
|
10
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
13 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
19K
|
6.6M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL Announces - Psi-GAD PIND and Ethics Approval
|
|
rhino78
|
87 |
26K |
12 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
87
|
26K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
rhino78
|
898 |
360K |
19 |
24/10/21 |
24/10/21 |
ASX - By Stock
|
898
|
360K
|
19
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
rhino78
|
898 |
360K |
14 |
23/10/21 |
23/10/21 |
ASX - By Stock
|
898
|
360K
|
14
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
rhino78
|
3.0K |
1.1M |
19 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
3.0K
|
1.1M
|
19
|
|
ASX - By Stock
|
IHL Biotech |
Re:
IHL - INCANNEX - HOLDERS RESEARCH
|
|
rhino78
|
1.2K |
536K |
15 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
1.2K
|
536K
|
15
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Appendix 3Y
|
|
rhino78
|
32 |
9.5K |
8 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
32
|
9.5K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
26 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
19K
|
6.6M
|
26
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
24 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
19K
|
6.6M
|
24
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
rhino78
|
898 |
360K |
27 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
898
|
360K
|
27
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Results of Meeting
|
|
rhino78
|
27 |
9.7K |
22 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
27
|
9.7K
|
22
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
10 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
19K
|
6.6M
|
10
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
rhino78
|
3.0K |
1.1M |
16 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
3.0K
|
1.1M
|
16
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Application for quotation of securities - IHL
|
|
rhino78
|
38 |
9.2K |
21 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
38
|
9.2K
|
21
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
8 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
19K
|
6.6M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
40 |
04/09/21 |
04/09/21 |
ASX - By Stock
|
19K
|
6.6M
|
40
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
13 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
19K
|
6.6M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
rhino78
|
19 |
7.5K |
24 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
19
|
7.5K
|
24
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL files Form F-1 registration statement with SEC
|
|
rhino78
|
129 |
52K |
9 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
129
|
52K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Roth Capital Partners to lead NASDAQ listing
|
|
rhino78
|
11 |
5.3K |
14 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
11
|
5.3K
|
14
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X patent update & open label extension study approval
|
|
rhino78
|
200 |
56K |
30 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
200
|
56K
|
30
|
|